Tag: retinal vein occlusion
Roche’s Vabysmo gains FDA approval for treating retinal vein occlusion
Pharma giant Roche has secured the U.S. FDA's approval for Vabysmo (faricimab) in treating macular edema after retinal vein occlusion (RVO). This becomes the third ... Read More
US biopharma company Longevity Biomedical to go public via Denali Capital
Longevity Biomedical, an American biopharmaceutical company, will go public through a merger with Denali Capital Acquisition Corp., a special purpose acquisition company. The combined entity ... Read More
KSI-301 phase 1b trial : Kodiak Sciences reports new safety, efficacy, and durability data
KSI-301 phase 1b trial : Kodiak Sciences said that its ongoing phase 1b clinical trial of its intravitreal anti-VEGF antibody biopolymer conjugate KSI-301 for the ... Read More